Bonesupport Cements Funding With SEK 500m IPO
Executive Summary
Swedish orthobiologics company Bonesupport has closed its initial public offering on the Nasdaq Stockholm exchange, raising SEK500m ($57m) from retail and institutional investors.
You may also be interested in...
Bonesupport Primed For Nasdaq Stockholm Flotation
Swedish orthobiologics company Bonesupport is seeking to raise SEK500m ($45m) by floating its shares publicly for the first time on the Nasdaq Stockholm stock exchange. Proceeds from the IPO will go towards advancing sales of its existing bone substitute products and conducting a major study to gain US approval of antibiotic-eluting bone filler Cerament G.
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
Angle Files De Novo Submission For Parsortix System In Breast Cancer
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.